METTL3 and neoplasm: Conversely, suppressing m6A levels via METTL3‐siRNA treatments suppressed SLC7A11 expression, allowing increased accrual of lipid ROS and consequent induced ferroptosis, thus preventing tumorigenesis of HB cancer cells and tumour growth in mice.